Crime is down. Migrant workers and customers are staying home. As part of our video series on Trump’s second term, The Wall Street Journal’s Michelle Hackman takes us inside the aftermath. Photo ...

At his highest, he weighed 540 pounds. This is how Jelly Roll went from preteen T-levels to Pink Panther energy and got lean.

As of January, California is the first state in the country to partner with a nonprofit to develop, produce and sell its own insulin as a solution to the widespread unaffordability of the life-saving ...

Controlling light at dimensions thousands of times smaller than the thickness of a human hair is one of the pillars of modern nanotechnology. An international team led by the Quantum Nano-Optics Group ...

A new, groundbreaking real-world evidence study in Diabetes Technology and Therapeutics analyzing 938,740 matched patients has found that continuous glucose monitor (CGM) use among individuals with ...

US researchers say a deep-learning framework provides the most detailed picture yet of how utility-scale solar uses land, revealing unexpected efficiency gaps and clearer pathways for agrivoltaics and ...

As Disney has gone into business with OpenAI, the Mouse House is accusing Google of copyright infringement on a “massive scale” using AI models and services to “commercially exploit and distribute” ...

A low-fat vegan diet with no restrictions on calories or carbohydrates led to significant reductions in insulin use and body weight among adults with type 1 diabetes (T1D), lowering daily insulin ...

A material that slips through skin might someday make needle-free insulin possible for people with diabetes. In mice and mini pigs, attaching the permeating polymer to insulin and applying the ...

If you’re on insulin to treat type 1 or type 2 diabetes, it’s critical to know exactly how to use it. “Insulin can be a very dangerous drug if used improperly,” says Stanley Mathew, MD, an ...

It is estimated that approximately 25%–30% of hospitalized adults have diabetes. Numerous studies have demonstrated the benefits of technological advances such as continuous glucose monitoring (CGM) ...

SAN DIEGO, CA / ACCESS Newswire / November 17, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 ...